Piper Sandler Reiterates “Overweight” Rating for Alphatec (NASDAQ:ATEC)
Piper Sandler restated their overweight rating on shares of Alphatec (NASDAQ:ATEC – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $15.00 target price on the medical technology company’s stock, up from their previous target price of $13.00. Several other equities research analysts have also recently […]
Piper Sandler restated their overweight rating on shares of Alphatec (NASDAQ:ATEC – Free Report) in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has a $15.00 target price on the medical technology company’s stock, up from their previous target price of $13.00. Several other equities research analysts have also recently […]
